SABS — SAB Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for SAB Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—
Source:	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	12.6	33.2	15	56.6
Net Total Accounts Receivable
Net Total Receivables	20.6	8.01	5.56	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	34.5	50.2	22.1	58.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	22.1	30.9	28.3	24.7
Other Long Term Assets
Total Assets	56.5	81.1	50.9	83.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.1	26.5	15	10.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.5	42.6	19.8	26.6
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	39	38.5	31.1	57.3
Total Liabilities & Shareholders' Equity	56.5	81.1	50.9	83.9
Total Common Shares Outstanding